Circulating Maternal Serum Cell Free Fetal DNA Levels for prediction of Preeclampsia

Serum Soluble Endoglin Versus Serum Placental Growth Factor for Early Prediction of Preeclampsia

Pregnancy-Associated Placental Protein A2/Placental Growth Factor Ratio Might Discriminate Normotensive Pregnant Women Who Are Liable to Develop Early-Onset Preeclampsia

High Serum Levels of Cardiac Troponin I., Tumor Necrosis Factor-Α and D-Dimer Could be Used as Early Predictors for Upcoming Preeclampsia and its Severity

MATERNAL VASCULAR ENDOTHELIAL MARKERS IN PREGNANCIES COMPLICATED BY PRE-ECLAMPSIA

Low Serum Pregnancy Protein 13 Early in Pregnancy might predict the oncoming Gestational Hypertensive Disorders, especially Early-onset Preeclampsia

Amyloid A as a biomarker for preeclampsia

EVALUATION OF MATERNAL SERUM ENDOGLIN IN PREECLAMPSIA AND IN NORMOTENSIVE PREGNANT FEMALES

The value of Serum Amyloid A in Preeclampsia

Inflammatory Markers in Pre-eclampsia